#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer stage III Pemphigoid Follicular lymphoma stage II Herpes simplex Graft versus host disease Gaucher's disease type III Loeys-Dietz syndrome Basal cell naevus syndrome Ewing's sarcoma recurrent Type IIa hyperlipidaemia Candida infection High-grade B-cell lymphoma Red blood cell abnormality Leukocyte adhesion deficiency Anaemia More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Life with Disease Phenylketonuria Lymphangiosarcoma – Trials in Disease Optic glioma Myelodysplastic syndrome with excess blasts – Treatment Hepatoblastoma – Diagnostics Wiskott-Aldrich syndrome Angiosarcoma metastatic – Trials in Disease Usher’s syndrome – Treatment Sjogren’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alteplase Colchicine Ammonium Chloride Fitusiran Tulisokibart Escitalopram Oxalate Maralixibat Chloride Lasmiditan Clofutriben Omx-0407 TRAZODONE HYDROCHLORIDE Nimorazole Dinoprostone Chlortalidone Zoledronic Acid Monohydrate Tx200-Tr101 Cefuroxime Clemastine Upadacitinib Av-Ec2023 More therapies…

    Learn about Your Condition

    Urethral valves Monkeypox Dystonia Immune thrombocytopenia Bipolar I disorder Idiopathic pulmonary fibrosis Cognitive disorder Adenocarcinoma of colon Schizoaffective disorder Corneal graft rejection Portal hypertension Injury Restless legs syndrome Pseudoxanthoma elasticum Onychomycosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Conjunctivitis allergic

  • Study on the Safety and Effectiveness of Subcutaneous Immunotherapy with Der p 1, Der p 2, and Der p 23 Allergens for Patients with Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Conjunctivitis
    • Conjunctivitis allergic
    Investigated Drugs:
    • Dermatophagoides Pteronyssinus
    Spain

  • Study on the Effectiveness and Safety of CLU-RX-DPT for Patients with Moderate-to-Severe House Dust Mite Allergy

    Not recruiting

    4 1
    Investigated Drugs:
    • Dermatophagoides Pteronyssinus Allergoid, Glutaraldehyde-Modified
    Germany Spain

  • Study on the Effectiveness of Cup a 1 Immunotherapy for Patients with Moderate to Severe Allergic Rhinoconjunctivitis with or without Controlled Asthma

    Not recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Spain

  • Study on the Effectiveness and Safety of a Grass and Olive Pollen Allergy Vaccine for Patients with Allergic Rhinitis or Asthma

    Not recruiting

    3 1
    Investigated Drugs:
    • Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Lolium Perenne Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified
    Spain

  • Study on the Effectiveness and Safety of Clustoid MM09 for Patients with Allergic Rhinitis or Rhinoconjunctivitis, with or without Mild to Moderate Asthma

    Not recruiting

    3 1
    Investigated Drugs:
    • Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
    • Dermatophagoides Pteronyssinus Allergoid, Glutaraldehyde-Modified
    Spain

  • Study on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Rhinitis allergic
    Investigated Drugs:
    • Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
    Germany Poland
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!